Search - tctmd.com

Displaying 781 - 800 of 985

Sort: Relevancy | Date

News Daily News

El Abordaje Transradial podría Equilibrar los Beneficios Hemorrágicos de la Bivalirudina en las PCI Primarias

Jason Kahn

January 15, 2014

News Daily News

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Yael L. Maxwell

January 09, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

Meta Análisis: La PCI No añade Beneficio alguno al Tratamiento Médico en Pacientes con Isquemia Demostrada

Yael L. Maxwell

December 08, 2013

Presentation

MGUARD Stent in STEMI - The MASTER I and MASTER II Trials

Presenter: Gregg W. Stone

December 01, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Presenter: Gilles Montalescot

October 31, 2013

Presentation TCT 2013

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

Presenter: Dariusz Dudek

October 31, 2013

Presentation TCT 2013

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Presenter: Praveen Chandra

October 31, 2013

News Conference News TCT 2013

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

October 30, 2013

Presentation TCT 2013

TCT-47. Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention With The STENTYS® Self-Apposing Coronary Stent In Patients Not Treated For STEMI.

Presenter: Huangling Lu

October 29, 2013

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes(2)

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Presenter: Dariusz Dudek

October 29, 2013

Presentation TCT 2013

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

Presenter: Gregg Stone

October 28, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Caitlin E. Cox

October 11, 2013

Advertisement

El Abordaje Transradial podría Equilibrar los Beneficios Hemorrágicos de la Bivalirudina en las PCI Primarias

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Meta Análisis: La PCI No añade Beneficio alguno al Tratamiento Médico en Pacientes con Isquemia Demostrada

MGUARD Stent in STEMI - The MASTER I and MASTER II Trials

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

EUROMAX: Prehospital Bivalirudin Reduces Bleeding in STEMI

TCT-47. Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention With The STENTYS® Self-Apposing Coronary Stent In Patients Not Treated For STEMI.

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes(2)

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

TCT-41. One-year Results From the MASTER Trial, a Prospective, Randomized, Multicenter Evaluation of an Embolic Protection Stent (MGuard) in Patients with STEMI Undergoing Prima...

Stents and Pharmacotherapy in STEMI: Anticipating HORIZONS-AMI II

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

INFUSE-AMI: El Descenso del Tamaño del Infarto a los 30 Días podría Traducirse en Beneficios al cabo de 1 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content